Magnetic nanoparticles for diagnosis and treatment

Cancer is a complex disease in which certain cells in the body grow uncontrollably and spread to other parts of the body. Although there have been advances observed in the diagnosis and treatment of cancer, many studies are conducted to eliminate the side effects that occur during treatment. Magnetic nanoparticles (MNPs) are of great interest in the field of cancer diagnosis and treatment due to their magnetic features, biocompatibility, and stability. These features allow them to be used as a contrast agent for magnetic resonance (MR) imaging as a therapeutic system with a drug release system and hyperthermia. MNP-based imaging, drug release systems, and hyperthermia treatments have been studied by researchers and reported to be promising for the treatment of various types of cancer. Although the clinical applications of MNPs for cancer treatment are still controversial, researchers think that MNPs will play an important role in meeting health needs in the future. In this review, we present advances in in-vitro and in-vivo research for diagnosis and treatment, besides an overview of the basic technical principles of MNPs

PDF

___

1. World Health Organization. Cancer. https://www.who.int/news-room/ factsheets/detail/cancer access date: 20.09.2021.
2. Lei S, Zheng R, Zhang S, et al. Global patterns of breast cancer incidence and mortality:A population‐based cancer registry data analysis from 2000 to 2020. Cancer Commun. 2021;41:1183-94.
3. Yiğitbaşı, T. Pers Kraliçesi Atossa ile geçmişten geleceğe kanserin yolculuğu.http://www.sdplatform.com/Dergi/770/Sehir-hastanelerindekalite-yonetimi-ve-saglikkampusleri-projesi.aspx access date: 18.08.2021.
4. Salmanian G, Hassanzadeh-Tabrizi SA, Koupaei N. Magnetic chitosan nanocomposites for simultaneous hyperthermia and drug delivery applications: A review. Int J Bıol Macromol. 2021;184:618-35.
5. Gulbahce-Mutlu E, Baltaci SB, Menevse E, et al. The effect of zinc and melatonin administration on lipid peroxidation, IL-6 levels, and element metabolism in DMBAinduced breast cancer in rats. Biol Trace Elem Res. 2021;199:1044-51.
6. Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med. 1999;106:574-82.
7. Yang Y. Cancer immunotherapy: harnessing the immune system to battle cancer. J Clin Invest. 2015;125:3335-7.
8. Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019;18:175-96.
9. Ehsani S, Saathian E, Sarikhani A, Montazerabadi A. 1 H-MRS application in the evaluation of response to photo-thermal therapy using iron oxidegold core-shell nanoparticles, an in vivo study. Photochem Photobiol Sci. 2021;20:245-54.
10. Mannu R, Karthikeyan V, Velu N, et al. Polyethylene glycol coated magnetic nanoparticles: Hybrid nanofluid formulation, properties and drug delivery prospects. Nanomaterials. 2021;11:440.
11. Mohammad F, Yusof NA. Doxorubicin-loaded magnetic gold nanoshells for a combination therapy of hyperthermia and drug delivery. J Colloid Interface Sci. 2014;434:89-97.
12. Erdoğan A. Kanser Tanı ve Tedavisinde Manyetik Nanopartikülker. Natural and Applied Sciences Journal. 2018;1:23-30.
13. Wickline SA, Neubauer AM, Winter PM, et al. Molecular imaging and therapy of atherosclerosis with targeted nanoparticles. JMRI. 2017;25:667- 80.
14. Corot C, Petry KG, Trivedi R, et al. Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Invest Radiol. 2004;39:619-25.
15. Yamany A, Aziz A. Superparamagnetic Nanoparticles for Cancer Theranostics: the challenges and the hope. 2016.
16. Cole AJ, Yang VC, David AE. Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends Biotechnol. 2011;29:323-32.
17. Patra S, Roy E, Karfa P, et al. Dual-responsive polymer coated superparamagnetic nanoparticle for targeted drug delivery and hyperthermia treatment. ACS Appl Mater Interfaces. 2015;7:9235-46.
18. Lee JH, Chen KJ, Noh SH, et al. On‐demand drug release system for in vivo cancer treatment through self‐assembled magnetic nanoparticles. Angew Chem Int Ed Engl. 2013;125:4480-84.
19. Dai G, Sun L, Xu J, et al. Catechol–metal coordination-mediated nanocomposite hydrogels for on-demand drug delivery and efficacious combination therapy. Acta Biomater. 2021;129:84-95.
20. El-Boubbou K. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance. Nanomedicine. 2018;13:953-71.
21. Farzin A, Etesami SA, Quint J, et al. Magnetic nanoparticles in cancer therapy and diagnosis. Adv Healthc Mater. 2020;9:1-29.
22. Khanna L, Verma NK, Tripathi SK. Burgeoning tool of biomedical applications- Superparamagnetic nanoparticles. J Alloys Compd. 2018;752:332-53.
23. Singh A, Sahoo SK. Magnetic nanoparticles: a novel platform for cancer theranostics. Drug Discov Today. 2014;19:474-81.
24. Wang G, Zhou F, Li X, et al. Controlled synthesis of L-cysteine coated cobalt ferrite nanoparticles for drug delivery. Ceram Int. 2018;44:13588-94.
25. Adhikary J, Chakraborty P, Das B, et al. Preparation and characterization of ferromagnetic nickel oxide nanoparticles from three different precursors: application in drug delivery. RSC Adv. 2015;5:35917-28.
26. Ghosh P, Han G, De M, et al. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev. 2008;60:1307-15.
27. Sun C, Lee JS, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev. 2008;60:1252-65.
28. Laurent S, Forge D, Port M, et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev. 2008;108:2064-110.
29. Corot C, Robert P, Idée JM, Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev. 2006;58:1471-504.
30. Zamay GS, Zamay TN, Lukyanenko KA, Kichkailo AS. Aptamers increase biocompatibility and reduce the toxicity of magnetic nanoparticles used in biomedicine. Biomedicines. 2020;8:59.
31. Sun C, Du K, Fang C, et al. PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo. ACS Nano. 2010;4:2402-10.
32. Cole AJ, David AE, Wang J, et al. Polyethylene glycol modified, crosslinked starchcoated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials. 2011;32:2183-93.
33. Huang HS, Hainfeld JF. Intravenous magnetic nanoparticle cancer hyperthermia. Int J Nanomedicine. 2013;8:2521-32.
34. Bazak R, Houri M, El AS, et al. Cancer active targeting by nanoparticles: a comprehensive review of literature. J Cancer Res Clin Oncol. 2015;141:769- 84.
35. Liu Y, Yuan M, Qiao L, Guo R. An efficient colorimetric biosensor for glucose based on peroxidase-like protein-Fe3O4 and glucose oxidase nanocomposites. Biosens Bioelectron. 2014;52:391-6.
36. Yigit MV, Mazumdar D, Kim HK, et al. Smart “turn‐on” magnetic resonance contrast agents based on aptamer‐functionalized superparamagnetic iron oxide nanoparticles. Chembiochem. 2007;8:1675-8.
37. Wunderbaldinger P, Josephson L, Weissleder R. Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjug Chem. 2002;13:264-8.
38. Weissleder R, Kelly K, Sun EY, et al. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol. 2005;23:1418-23.
39. Dowaidar M, Nasser Abdelhamid H, Hällbrink M, et al. Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nanoparticles– cell-penetrating peptide. J Biomater Appl. 2018;33:392-401.
40. Reddy GR, Bhojani MS, McConville P, et al. Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin Cancer Res. 2006;12:6677- 86.
41. Pala K, Serwotka A, Jeleń F, et al. Tumor-specific hyperthermia with aptamer-tagged superparamagnetic nanoparticles. Int J Nanomedicine. 2014;9:67-76.
42. Singh A, Sahoo SK. Magnetic nanoparticles: a novel platform for cancer theranostics. Drug Discov Today. 2014;19:474-81.
43. Wu LC, Zhang Y, Steinberg G, et al. A review of magnetic particle imaging and perspectives on neuroimaging. AJNR. 2019;40:206-12.
44. Valdiglesias V, Kiliç G, Costa C, et al. Effects of iron oxide nanoparticles: cytotoxicity, genotoxicity, developmental toxicity, and neurotoxicity. Environ Mol Mutagen. 2015;56:125-48.
45. Yu F, Zhang L, Huang Y, et al. The magnetophoretic mobility and superparamagnetism of core-shell iron oxide nanoparticles with dual targeting and imaging functionality. Biomaterials. 2010;31:5842-8.
46. Duan H, Kuang M, Wang, et al. Reexamining the effects of particle size and surface chemistry on the magnetic properties of iron oxide nanocrystals: new insights into spin disorder and proton relaxivity. J Phys Chem C. 2008;112:8127-31.
47. Wáng YXJ, Idée JM. A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging. Quant Imaging Med Surg. 2017;7:88-122.
48. Daldrup-Link HE. Ten things you might not know about iron oxide nanoparticles. Radiology. 2017; 284:616-29.
49. Stueber DD, Villanova J, Aponte I, et al. Magnetic nanoparticles in biology and medicine: past, present, and future trends. Pharmaceutics. 2021;13:943.
50. Aydın RST. Herceptin‐decorated salinomycin‐loaded nanoparticles for breast tumor targeting. J Biomed Mater Res A. 2013;101:1405-15.
51. Sun C, Veiseh O, Gunn J, et al. In vivo MRI detection of gliomas by chlorotoxinconjugated superparamagnetic nanoprobes. Small. 2008;4:372- 9.
52. Liu HL, Hua MY, Yang HW, et al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc Natl Acad of Sci USA. 2010;107:15205-10.
53. Hałupka-Bryl M, Asai K, Thangavel S, et al. Synthesis and in vitro and in vivo evaluations of poly (ethylene glycol)-block-poly (4-vinylbenzylphosphonate) magnetic nanoparticles containing doxorubicin as a potential targeted drug delivery system. Colloids Surf B Biointerfaces. 2014;118:140-7.
54. Shakeri-Zadeh A, Khoee S, Shiran MB, et al. Synergistic effects of magnetic drug targeting using a newly developed nanocapsule and tumor irradiation by ultrasound on CT26 tumors in BALB/c mice. J Mater Chem B. 2015;3:1879-87.
55. Holladay RT. Incorporating magnetic nanoparticle aggregation effects into heat generation and temperature profiles for magnetic hyperthermia cancer treatments. Doctoral dissertation, Virginia Tech. 2016.
56. Ma G, Jiang G. Review of tumor hyperthermia technique in biomedical engineering frontier. BMEI. 2010;4:1357-9.
57. Pennacchioli E, Fiore M, Gronchi A. Hyperthermia as an adjunctive treatment for softtissue sarcoma. Expert Rev Anticancer Ther. 2009;9:199- 210.
58. Hedayatnasab Z, Abnisa F, Daud WMAW. Review on magnetic nanoparticles for magnetic nanofluid hyperthermia application. Materials Design. 2017;123:174-96.
59. Buu MC, Carter L, Bruce JS, et al. Asthma, tobacco smoke and the indoor environment: a qualitative study of sheltered homeless families. J Asthma. 2014;51:142-8.
60. Kumar CS, Mohammad F. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv Drug Deliv Rev. 2011;63:789- 808.
61. Johannsen M, Thiesen B, Jordan A, et al. Magnetic fluid hyperthermia (MFH) reduces prostate cancer growth in the orthotopic Dunning R3327 rat model. Prostate. 2005;64:283-92.
62. Basel MT, Balivada S, Wang H, et al. Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model. Int J Nanomedicine. 2012;7:297-306.
63. Lee JH, Chen KJ, Noh SH, et al. On‐demand drug release system for in vivo cancer treatment through self‐assembled magnetic nanoparticles. Angew Chem. 2013;125:4384-8.
64. Mondal S, Manivasagan P, Bharathiraja S, et al. Hydroxyapatite coated iron oxide nanoparticles: a promising nanomaterial for magnetic hyperthermia cancer treatment. Nanomaterials. 2017;7:426.